RNA silencing nanozymes
AssigneeUniversity of Florida Research Foundation, Inc.
InventorsYunwei Charles Cao, Tian Jiang
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Florida Research Foundation, Inc.
InventorsYunwei Charles Cao, Tian Jiang
Estimating the term…
Disclosed herein are improved nanozymes for targeting RNA. The disclosed nanozymes are synthesized using recombinant RNase A with site-specific cysteine-substituted mutations that can be covalently functionalized with a length-tunable multi-thiol tether and then loaded onto gold particles through multiple gold-sulfur bonds. This new RNase A loading mechanism is site specific, and it allows high-density loading of alkylthiol modified DNA oligonucleotides. The disclosed nanozymes can also include additional capturer strands and/or involve DNA-recombinant-RNase-A unibodies to further increase the nanozyme's enzymatic activity and target selectivity. Also disclosed are functional on-off switchable nanozymes to control nanozyme activity. In some embodiments, the disclosed nanozyme are core-free hollow forms. The removal of the inorganic nanoparticle cores from nanozymes can effectively eliminate the potential long-term toxicity induced by the core, and also creates a cavity for loading and delivery of small molecule drugs.
A nanozyme comprising a gold nanoparticle, an engineered ribonuclease-A enzyme and a DNA oligonucleotide,
Dependencies are inferred from the claim text.